These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8851584)
1. Antituberculosis activities of clofazimine and its new analogs B4154 and B4157. Reddy VM; Nadadhur G; Daneluzzi D; O'Sullivan JF; Gangadharam PR Antimicrob Agents Chemother; 1996 Mar; 40(3):633-36. PubMed ID: 8851584 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. Jagannath C; Reddy MV; Kailasam S; O'Sullivan JF; Gangadharam PR Am J Respir Crit Care Med; 1995 Apr; 151(4):1083-6. PubMed ID: 7697235 [TBL] [Abstract][Full Text] [Related]
3. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis]. Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635 [TBL] [Abstract][Full Text] [Related]
5. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis. De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agents. Zhang D; Liu Y; Zhang C; Zhang H; Wang B; Xu J; Fu L; Yin D; Cooper CB; Ma Z; Lu Y; Huang H Molecules; 2014 Apr; 19(4):4380-94. PubMed ID: 24722591 [TBL] [Abstract][Full Text] [Related]
7. Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice. Verma RK; Germishuizen WA; Motheo MP; Agrawal AK; Singh AK; Mohan M; Gupta P; Gupta UD; Cholo M; Anderson R; Fourie PB; Misra A Antimicrob Agents Chemother; 2013 Feb; 57(2):1050-2. PubMed ID: 23183441 [TBL] [Abstract][Full Text] [Related]
8. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Rastogi N; Labrousse V; Goh KS Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093 [TBL] [Abstract][Full Text] [Related]
9. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis. van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797 [TBL] [Abstract][Full Text] [Related]
10. Xu J; Wang B; Fu L; Zhu H; Guo S; Huang H; Yin D; Zhang Y; Lu Y Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782992 [TBL] [Abstract][Full Text] [Related]
11. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation. Lu Y; Zheng M; Wang B; Fu L; Zhao W; Li P; Xu J; Zhu H; Jin H; Yin D; Huang H; Upton AM; Ma Z Antimicrob Agents Chemother; 2011 Nov; 55(11):5185-93. PubMed ID: 21844321 [TBL] [Abstract][Full Text] [Related]
12. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169). Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954 [TBL] [Abstract][Full Text] [Related]
13. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy. Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR mBio; 2018 May; 9(3):. PubMed ID: 29844114 [TBL] [Abstract][Full Text] [Related]
14. Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents. Bvumbi MV ChemMedChem; 2020 Dec; 15(23):2207-2219. PubMed ID: 32844566 [TBL] [Abstract][Full Text] [Related]
15. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo]. Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601 [TBL] [Abstract][Full Text] [Related]
18. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis. Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727 [TBL] [Abstract][Full Text] [Related]
19. A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid. Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A J Clin Microbiol; 2016 Dec; 54(12):2963-2968. PubMed ID: 27654338 [TBL] [Abstract][Full Text] [Related]